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Marek’s disease virus (MDV), the etiologic agent of Marek’s disease, is a potent oncogenic herpesvirus. MDV
is highly contagious and elicits a rapid onset of malignant T-cell lymphomas in chickens within several weeks
after infection. MDV genome codes an oncoprotein, Meq, which shares resemblance with the Jun/Fos family
of bZIP transcription factors. Similar to Jun, the leucine zipper region of Meq allows the formation of homo-
and heterodimers. Meq homo- and heterodimers have different DNA binding affinities and transcriptional
activity; therefore, they may differentially regulate transcription of viral and cellular genes. In this study we
investigated the role of Meq homodimers in the pathogenicity of MDV by generating a chimeric meq gene,
which contains the leucine zipper region of the yeast transcription factor GCN4 (meqGCN). A recombinant
virus (rMd5-MeqGCN) containing the chimeric meqGCN gene in place of parental meq was generated with
overlapping cosmid clones of Md5, a very virulent MDV strain. The rMd5-MeqGCN virus replicated in vitro
and in vivo but was unable to transform T cells in infected chickens. These data provide the first in vivo
evidence that Meq homodimers are not sufficient for MDV-induced transformation.
Marek’s disease virus (MDV), the etiologic agent of Marek’s
disease, is a potent oncogenic herpesvirus that elicits a rapid onset
of malignant T-cell lymphomas in chickens within several weeks
of infection, resulting in mortality. MDV is classified as an alpha-
herpesvirus based on viral genome organization and sequence but
shares biological characteristics with gammaherpesviruses, such
as its tropism and its ability to transform lymphocytes (33). Of the
previously described serotypes of MDV, now classified as Gallid
herpesvirus 2 (GaHV-2) or MDV serotype 1 (MDV-1), GaHV-3
or MDV-2, and the Meleagrid herpesvirus 1 (MeHV-1) or turkey
herpesvirus, only MDV-1 is oncogenic. In addition, a number of
different pathotypes exist within MDV-1 ranging from mild to
very virulent plus (3, 39).
The search for candidate viral oncogenes in the MDV ge-
nome led to the discovery of meq, which is abundantly ex-
pressed in MDV transformed cells and is encoded only by the
genome of MDV-1. The meq gene is named after the EcoQ
fragment where it is located (i.e., Marek’s EcoQ), and two
copies are found in the viral genome within the terminal repeat
long (TRL) and internal repeat long (IRL) regions (28, 32, 33,
37). Meq, a 339-amino-acid nuclear phosphoprotein, is a bZIP
(basic-region leucine zipper) protein, which shares significant
homology, in the bZIP domain, with the proto-oncogene c-Jun,
a transcription factor of the AP-1 (activating protein) complex
(13, 22, 24). AP-1 transcription factors are a group of well-
described proteins that are characterized by their ability to
bind and regulate sequence-specific gene elements, AP-1 sites,
which are found in many genes associated with cell prolifera-
tion (35). Transformation by deregulated expression of c-Jun
or its viral counterpart v-Jun is well documented, and therefore
the shared homology between Meq and Jun is intriguing (38).
In vitro data support the oncogenic nature of Meq, which can
promote anchorage-independent growth, cell cycle progres-
sion, and antiapoptosis (23, 24). Recently, in vitro expression
of Meq was shown to upregulate genes similar to those up-
regulated by v-Jun, suggesting that Meq transforms via a v-Jun
transforming pathway (20). In addition, knockdown of c-jun
diminishes Meq’s transforming ability in vitro, strongly sug-
gesting that a Meq/Jun partnership plays a key role in Meq’s
oncogenic properties. However, the most convincing evidence
for Meq’s oncogenic property was the characterization of a
Meq-null recombinant MDV virus (rMd5Meq) which repli-
cated in chickens and did not induce tumors (25). Significantly,
the Meq-null virus also provided better protection than cur-
rently available vaccines in chickens upon challenge with the
most virulent strains of MDV (18), pointing to a potential
strategy for further vaccine improvement, wherein more subtle
mutation(s) of Meq are engineered, to abolish its transforming
ability, while retaining its ability of establishing infection in
vivo and associated antigenicity. To this end, it is important to
further dissect the transforming and replication functions of
Meq, which at present remain largely unexplored.
Like Jun, the leucine zipper region of Meq allows the for-
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mation of homodimers and heterodimers (21). It has been
shown that dimerization partners of bZIP proteins are impor-
tant determinants of DNA binding specificity and therefore
transcriptional regulation. For example, different Jun dimers
have been shown to play distinct roles in transformation, i.e.,
anchorage- or serum-independent growth (38). Again, simi-
larly to Jun, the DNA binding properties of Meq depend on its
dimerization partner. Previous characterization of the in vitro
DNA binding properties of Meq revealed that Meq-Jun het-
erodimers bind AP-1 sequences, whereas Meq homodimers in
addition to AP-1 sequences also bind sequences found at the
MDV origin of replication (Ori) (21, 29). Transcriptional anal-
ysis of Meq on the AP-1 containing meq promoter and the
MDV pp14/38 bidirectional promoter which contains the
MDV Ori revealed that Meq transactivates the meq promoter
but represses the bidirectional pp14/38 promoter. Because
Meq has been shown to bind the MDV Ori, it is possible that
Meq homodimers repress the pp38/14 promoter by binding this
sequence element. In addition to regulating pp38 expression,
an MDV protein highly expressed during lytic infection, Meq
was also shown to bind the ICP4 promoter by chromatin im-
munoprecipitation analyses. Therefore, Meq may also poten-
tially regulate the expression of an additional lytic protein
ICP4 (21, 29). This, together with luciferase reporter data,
suggests that Meq heterodimers activate AP-1 containing pro-
moters, therefore potentially activating genes associated with
cell proliferation, whereas Meq homodimers may repress
genes associated with lytic infection and consequently may be
involved in regulating lytic or latent infection. Collectively,
these data point to a role of Meq heterodimers in transforma-
tion and Meq homodimers in the regulation of viral replica-
tion. In order to delineate the functions of Meq and address
the role of Meq homodimers in MDV pathogenesis, a recom-
binant Meq mutant virus (rMd5-MeqGCN) expressing a chi-
meric meq gene (MeqGCN) was constructed by substituting the
parental Meq leucine zipper with that of the leucine zipper of
the yeast protein GCN4. The leucine zipper region of GCN4
allows for the formation of only homodimers (16), thus con-
ferring homodimerization of MeqGCN. The homodimeriza-
tion and DNA binding and transactivation/repression proper-
ties of MeqGCN were tested in vitro. Recombinant virus
expressing MeqGCN was studied in vitro and in vivo and
compared to parental rMd5 and rMd5Meq viruses. In vitro,
rMd5-MeqGCN replicated similarly to parental rMd5; how-
ever, infection of chickens with rMd5-MeqGCN did not result
in tumor formation. We therefore present the first in vivo
evidence that Meq homodimers are not sufficient for MDV
induced transformation. Our data also showed that subtle mu-
tations of Meq are effective in generating a nonvirulent recom-
binant MDV, paving the way to the development of improved
recombinant vaccine based on Meq mutations.
MATERIALS AND METHODS
Cells and viruses. Primary duck embryonic fibroblasts (DEF) were used for
virus propagation, virus reactivation assay, growth curves and DNA transfec-
tions. Recombinant viruses were generated from cosmids derived from a very
virulent MDV strain, Md5 (30). The previously described rMd5Meq was also
used in the present study (25). Chicken embryonic fibroblasts (CEF) were inoc-
ulated with rMd5-MeqGCN virus to obtain viral DNA used for transfection to
recover a revertant virus (rMd5-MeqGCNR). The DF-1 cell line was used for
luciferase assays and coimmunoprecipitation experiments (15). DEF and CEF
were maintained in Leibowitz-McCoy (LM) medium supplemented with 5%
bovine calf serum and penicillin-streptomycin at 37°C. The DF-1 cell line was
maintained in LM medium supplemented with 4% fetal bovine serum and
penicillin-streptomycin at 37°C.
Cosmids. Previously described cosmids SN5, P89, SN16, A6, and B40, encom-
passing the entire genome of the very virulent strain Md5 (30), were used to
generate a recombinant Md5 (rMd5) virus and a recombinant Md5 with a
chimeric Meq gene containing the leucine zipper from GCN4 (Fig. 1 and 2).
To generate mutations in the meq gene, a 741-bp DNA fragment referred
herein as meq-KpnI, which contains the coding sequence for meq nucleotides 1
to 385, was mutated by a series of subcloning steps and overlapping PCR. The
meq-KpnI fragment is located within the EcoQ fragment of the Md5 genome
(Fig. 1). First, the EcoQ fragment was released from previously described cos-
mids A6 and SN5 by using the recA assisted restriction endonuclease (RARE)
method (7). Briefly, recA and the primers SR1116 (5-GAA TCG GAT TTG
GAA TAA CCG AAT TCG GTG ATA TAA AGA C-3) and SR1117 (5-GAC
ATT ACA AGA ATA GTT TGA ATT CTC GGG ATA ATC TCC C-3) were
used to protect the flanking EcoRI sites of the EcoQ fragment during the EcoRI
methylation reaction. The unmethylated EcoRI sites were digested with EcoRI
releasing the EcoQ fragment, which was subsequently cloned into pCR2.1 (In-
vitrogen, Carlsbad, CA). The digested A6 and SN5 cosmids were self-ligated,
generating A6EcoQ and SN5EcoQ and HB101 competent bacteria trans-
duced using Gigapack III (Stratagene, La Jolla, CA) according to the manufac-
turer’s recommendations. Next, the meq-KpnI fragment was released from
pCR2.1-EcoQ by digestion with KpnI, and the fragment was gel purified, using
the QIAEX II gel extraction kit (Qiagen, Valencia, CA), and cloned into KpnI-
digested pCR2.1 vector. Overlapping PCR, in a combination of three PCRs, was
FIG. 1. Cosmid clones used to recover recombinant viruses.
(A) Organization of the serotype 1 MDV genome. (B) Schematic
representation of the overlapping cosmid clones used to reconstitute
recombinant viruses rMd5 and rMeqGCN, derived from a very virulent
strain of MDV (Md5). (C) Location of EcoQ fragment and Meq gene
in cosmids SN5 and A6. (D) Location of KpnI site described in Ma-
terials and Methods, located within the EcoQ fragment at nucleotide
385 of the meq gene.
FIG. 2. Schematic representation of the meq gene. The DNA bind-
ing basic regions (BR1 and BR2) and transactivation domains are
depicted. The leucine zipper (LZ) sequence of parental meq and
GCN4 used to replace parental meq LZ in rMd5-MeqGCN are shown.
Asterisks indicate the conserved leucine sites.
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performed to replace the leucine zipper region of meq with the leucine zipper
region of GCN4. Two primary PCRs were performed to generate the 5 and 3
ends of meq-KpnI fragment. The 5 reaction was performed using the primers
M13R (5-CAG GAA ACA GCT ATG AC-3) and SR1192-GCN4 leucine
zipper reverse (5-CTC ATT TTC CAA GTG ATA ATT TTT CGA AAG CAA
TTC TTC AAC CTT GTC TTC AAG TTT GTC TAC ATA GTC CGT CTG
CTT CCT-3). 3-end PCR was performed using the primers SR1190 (5-GAC
CGA GAT AGG GTT GAG TG-3) and SR1193-GCN4 leucine zipper forward
(5-AAA AAT TAT CAC TTG GAA AAT GAG GTT GCC AGA TTA AAG
AAA TTA GTT GGC GAA CGC CGT GTA CAG TTG GCT TGT CAT GAG
CCA-3). Both amplicons were gel purified, mixed together, and used as tem-
plates in a third PCR with the primers M13R and SR1190, generating a full
meq-KpnI fragment containing the GCN4 leucine zipper in place of the meq
leucine zipper (meq-GCN4-KpnI). The meq-GCN4-KpnI fragment was subse-
quently cloned into pCRBlunt (Invitrogen) transformed into Escherichia coli
TOP 10 cells, and positive clones were identified by restriction digestion and fully
sequenced. The meq-GCN4-KpnI fragment was then released by KpnI digestion
and cloned into pcr2.1-EcoQKpnI, replacing the parental meq-KpnI fragment
contained in this region. The newly generated EcoQ fragment (EcoQ-MeqGCN)
containing the mutated meq leucine zipper (MeqGCN) was then transferred into
cosmids A6EcoQ and SN5EcoQ, using RARE. The EcoRI site of cosmids
A6EcoQ and SN5EcoQ was protected during the methylation reaction using
recA and primer SR1130 (5-GAA TCG GAT TTG GAA TAA CCG AAT TCT
CGG GAT AAT CTC CCG ATG G-3), subjected to EcoRI restriction diges-
tion to linearize the cosmids, and subsequently ligated to the EcoQ-MeqGCN
fragment, yielding cosmids SN5-MeqGCN and A6-MeqGCN. After ligation and
transduction, clones containing the Eco-MeqGCN fragment in the correct ori-
entation were identified by PCR, and selected positive colonies were sequenced
across the junction regions. The integrity of the SN5-MeqGCN and A6-
MeqGCN cosmids was confirmed by evaluating their restriction digestion pat-
tern.
Transfections. Parental and mutant cosmid DNA were digested with NotI to
release the viral insert and purified by phenol-chloroform extraction and ethanol
precipitation before transfection. To generate rMd5 and rMd5-MeqGCN, 500 ng
of cosmids P89, SN16, B40, SN5, and A6 or P89, SN16, B40, SN5-MeqGCN, and
A6-MeqGCN, respectively, were used to transfect 1.2  106 DEF in 60-mm
dishes by the calcium phosphate procedure. At 5 days posttransfection, cells were
trypsin treated, seeded onto a 100-mm dish, and monitored for cytopathic effects.
Viral stocks of recovered viruses were subsequently made in DEF for further
analysis.
Revertant virus. To generate a revertant virus containing the parental meq
gene, gel-purified parental Md5 EcoQ fragment, together with proteinase K-
digested and phenol-chloroform extracted rMd5-MeqGCN genomic DNA, was
used to cotransfect CEF by the calcium phosphate procedure. After viral plaques
were evident, the cells were overlaid with 0.9% Bacto agar in growth media, and
individual plaques were harvested by trypsinization. Cells from each plaque were
divided into two aliquots: one was used to infect DEF, and the other was used for
DNA extraction and PCR analysis. The presence of parental meq or GCN4
leucine zipper sequences in individual plaques was detected by PCR using the
SR1118-meq start primer (5-GAT CCC GGG GAG ATG TCT CAG GAG
CCA GAG C-3) and the leucine zipper specific reverse primer SR3073-meq
leucine zipper (5-GTC CTT AGA TCT CGA ATT TCC -3) SR3074-GCN4
leucine zipper (5-CTA ATT TCT TTA ATC TGG CAA C-3) for parental and
GCN4 sequences, respectively.
IFA and IHC. Confluent DEF monolayers were infected with rMd5 or rMd5-
MeqGCN and, when viral plaques were apparent, cells were fixed with ice-cold
acetone-alcohol (6:4), and the expression of Meq was evaluated by indirect
immunofluorescence assay (IFA) using rabbit polyclonal anti-Meq antibodies
(1:300). Lymphocytes collected for reactivation assays were deposited on a mi-
croscope slide using a cytospin centrifuge, fixed with ice-cold acetone/alcohol
(6:4), and the expression of pp38 was evaluated by IFA using the H19 pp38
specific monoclonal antibody (1:400). For immunohistochemistry (IHC), lym-
phoid organs (thymus, spleen, and bursa of Fabricius), and feather follicles from
infected and uninfected chickens were embedded in optimal cutting temperature
compound (Tissue-Tek OCT; Sakura Finetek, Torrance, CA), immediately fro-
zen in liquid nitrogen, and stored at80°C until use. Cryostat sections (6 to 8 m
thick) of tissue were prepared, fixed with cold acetone at 20°C for 5 min, and
air dried. Immunostaining was carried out with H19 pp38 monoclonal antibody
(1:3,000) and the Vectastain ABC kit (Vector Laboratories, Burlingame, CA)
according to the manufacturer’s instructions.
MeqGCN homodimerization. For in vitro homodimerization assays, parental
meq and MeqGCN were cloned into the pcDNA3.1 (Invitrogen) eukaryotic
expression vector. Both meq and MeqGCN genes were cloned in frame with
hemagglutinin (HA) and Flag tags to aid in protein detection (12). The resulting
plasmids were denoted as pHA-MeqGCN, pFlag-MeqGCN, pHA-Meq, and
pFlag-Meq.
DF-1 cells were cotransfected with 2 g of either pFlag-Meq or pFlag-
MeqGCN and 2 g of pHA-Meq-, pHA-MeqGCN, pCMV-cJun, or pRCAS-
cFos using Fugene 6 (Roche, Mannheim, Germany). pCMV-cJun and pRCAS-
cFos were generous gifts from Junnlin Liu, M. D. Anderson Cancer Center).
Cells were harvested 48 h after transfection and lysed in radioimmunoprecipi-
tation assay buffer (10 mM Tris-HCl [pH 7.4], 1% NP-40, 0.1% sodium deoxy-
cholate, 150 mM NaCl, 1 mM EDTA, 1 mM phenylmethylsulfonyl fluoride). Cell
lysates (500 l) were immunoprecipitated with 20 l of Flag antibody-conjugated
agarose beads (Sigma, St. Louis, MO). Meq/c-Jun or Meq/c-Fos heterodimers
were immunoprecipitated with 3 g of either anti-cFos antibody (Santa Cruz,
Santa Cruz, CA) or anti-cJun antibody (Santa Cruz) for 2 h. The immune
complex was then captured by the addition 20 l of a protein A- and protein
G-Sepharose bead mixture and rocked for an additional 2 h at 4°C. Beads were
washed four times with radioimmunoprecipitation assay buffer, boiled for 5 min
in 20 l of 2 sodium dodecyl sulfate (SDS) sample buffer (125 mM Tris-HCl
[pH 6.8], 4% SDS, 10% 2-mercaptoethanol, 20% glycerol, 0.6% bromophenol
blue), and subjected to SDS-polyacrylamide gel electrophoresis, and transferred
to polyvinylidene difluoride membranes. After blocking for 1 h at room temper-
ature with 5% skim milk in TBST (20 mM Tris-HCl [pH 7.5], 137 mM NaCl,
0.05% Tween 20), the membranes were incubated with primary antibodies for 2 h
at room temperature. The membranes were washed with TBST three times for
10 min each time at room temperature and then incubated with horseradish
peroxidase-conjugated antibodies for 1 h at room temperature. Membranes were
washed three times with TBST and visualized with enhanced chemiluminescence
reagent (Amersham-Pharmacia, Piscataway, NJ). The final dilutions of the pri-
mary antibodies for immunoblotting were 1:500 for anti-HA tag antibody (Co-
vance, Berkeley, CA), 1:4,000 for anti-Meq (20), 1 g/ml for anti-cFos (Santa
Cruz), and 1 g/ml for anti-cJun (Santa Cruz).
Expression of recombinant Meq and MeqGCN proteins. Recombinant paren-
tal Meq and MeqGCN proteins were produced using a baculovirus expression
system (Invitrogen). Parental meq and meqGCN genes were cloned into a mod-
ified pFAST-BAC vector, which carries a Flag tag. One hundred million Sf9 cells
were infected with recombinant baculoviruses, expressing either Flag-tagged
Meq (Flag-Meq) or Flag-tagged MeqGCN (Flag-MeqGCN). Cells were har-
vested 48 h after infection and lysed in lysis buffer (50 mM Tris-HCl [pH 7.5], 500
mM NaCl, 2% glycerol) supplemented with protease inhibitor cocktail (Roche).
Cleared lysates were incubated overnight with 100 l of Flag antibody-conju-
gated agarose beads, followed by four washes with lysis buffer. Recombinant
proteins were then eluted with 3 Flag peptides according to the manufacturer’s
protocol. The purity and concentration of protein was measured by SDS-poly-
acrylamide gel electrophoresis and Coomassie blue staining using bovine serum
albumin as a standard.
EMSA. Electrophoretic mobility shift assay (EMSA) analysis was performed
with baculovirus-expressed recombinant purified Meq proteins. The DNA bind-
ing activity of Flag-Meq and Flag-MeqGCN was tested with two different probes,
an AP-1 consensus oligonucleotide (5-CGC TTG ATG AGT CAG CCG GAA-
3; Promega, Madison, WI) and a probe derived from the MDV Ori (5-TGC
TCA TTT GCA TAC ACA TCA CGT GAT AGT-3). Probes were labeled at
the 5 ends with [32P]ATP and polynucleotide kinase according to the manufac-
turer’s instructions (Promega). Purified recombinant Meq or MeqGCN proteins
(160 ng) were incubated for 20 min at 30°C in gel shift buffer (Promega),
followed by an additional 20 min incubation with approximately 10,000-cpm-
labeled probe. For competition reactions, purified proteins were first incubated
with unlabeled probes for 20 min at 30°C prior to incubation with labeled probes.
Reaction products were resolved on nondenaturing 6% polyacrylamide-Tris-
glycine gels and visualized using a Fuji Film Bas-1800 II phosphorimaging sys-
tem.
Luciferase assays. The transactivation and repression activities of the
MeqGCN protein were evaluated on MDV promoters by luciferase assay. The
meq promoter region (nucleotides 355 to 1) was cloned into the pGL3 vector
(Promega) to form the pGL3-meq promoter. The pp38 and pp14 promoters were
cloned into the pGL3 reporter vector and have been previously described (21).
Three tandem copies of the MDV Ori sequence (TGC TCA TTT GCA TAC
ACA TCA CGT GAT AGT) found within the pp38/pp14 bidirectional promoter
were cloned into the pGL2-TATA luciferase vector (kindly provided by Stephen
Safe, Texas A&M University) to generate pGL2-3XOri. The meq and MeqGCN
genes were cloned into the pcDNA 3.1 Zeo vector (Invitrogen) to generate
expression vectors, pcDNA-Meq, and pcDNA-MeqGCN. DF-1 cells (105) were
seeded in 12-well plates at 16 h prior to transfection and incubated at 37°C under
standard conditions. Transfections were performed by using siPORT XP-1
VOL. 83, 2009 HOMODIMERIZATION OF MDV-ENCODED Meq PROTEIN 861
 o
n
 Septem
ber 12, 2018 by guest
http://jvi.asm.org/
D
ow
nloaded from
 
(Ambion, Austin, TX); 500 ng of pcDNA (empty vector control), pcDNA-Meq,
or pcDNA-MeqGCN; and either 250 ng of pGL3-meq promoter vector, pGL2-
Ori, or 500 ng of pp38 and pp14 promoter vectors, according to manufacturer’s
recommendations. Cell lysates were harvested at 48 h posttransfection with
active lysis buffer (Promega), and luciferase activity was measured, using a Biotek
Clarity luminometer (Biotek, Winooski, VT). The protein concentration in each
transfected sample was measured by a Bradford assay (Bio-Rad, Hercules, CA),
and the luciferase activity was normalized to protein concentration. Assays were
performed in triplicate, and three independent experiments were performed for
each reporter vector tested. The transactivation or transrepression activity was
expressed as the fold difference relative to the empty pcDNA vector control. The
results of all three experiments were analyzed by one-way analysis of variance,
followed by a Tukey’s HSD test using the SPSS version 14.0 software (SPSS, Inc.,
Chicago, IL). For all analysis, a P value of 0.05 was considered statistically
significant.
Colony formation in soft agar. DF-1 cells were transfected with pcDNA,
pcDNA-Meq, or pcDNA-MeqGCN using siPORT XP-1 (Ambion). Approxi-
mately 48 h after transfection the transfected DF-1 cells were selected with 300
g of zeocin (Invitrogen)/ml for 4 weeks. The expression of Meq was confirmed
by IFA using Meq antibody as described above. Pools of resistant cells (5  103)
were seeded in 0.33% agarose containing LM media with 150 g of zeocin/ml
and 10% FBS overlaid on a 0.5% agarose in a 35-mm plate. After 3 weeks of
culture, the colonies were examined under a light microscope and photographed
using 12 magnification. Three different fields were randomly selected, and
colonies greater than 100 m were counted. Two independent experiments were
performed, and each experiment was performed in triplicate.
Southern blot. DNA from rMd5, rMd5-MeqGCN, and rMd5Meq-infected
DEF was isolated by proteinase K digestion, followed by phenol-chloroform
extraction and ethanol precipitation. Portions (3 g) of each DNA sample were
digested with either EcoRI or PstI, separated on a 1% agarose gel, and trans-
ferred to nylon membranes. [32P]dCTP-labeled probes representing the com-
plete MDV genome (cosmids SN5, P89, SN16, A6, and B40) or EcoQ fragment
(2,456-bp fragment) were generated by random priming using a High Prime
DNA labeling kit (Roche) and used to hybridize to viral DNA according to
standard protocols (34).
In vitro growth kinetics. To compare the growth characteristics of rMd5 and
rMd5-MeqGCN, DEF seeded on 35-mm plates were inoculated with approxi-
mately 50 PFU of each virus. On days 2, 4, and 6 after inoculation, the infected
cells were trypsinized, serial dilutions were inoculated onto DEF monolayers and
seeded onto 35-mm plates, and plaques at the different dilutions were counted 7
days later.
Pathogenesis experiments. (i) Experiment 1. To study the effect of Meq
homodimers on viral replication, 4-week-old specific-pathogen-free (SPF) chick-
ens (Hy-Vac, Adel, Iowa) were randomly sorted into experimental groups of nine
chickens each. One group remained as a noninoculated control, whereas the
other groups were inoculated subcutaneously with 3,000 PFU of rMd5, rMd5-
MeqGCN, or rMd5Meq. Three chickens were randomly selected at each time
point, except at day 6, when two chickens were selected. On days 14 and 21
postinfection, blood samples were collected in heparin for reactivation assays
(see below) and were subsequently euthanized for tissue sample collection. On
days 6 and 21 postinfection, lymphoid organs and feather follicles were collected
for IHC. On day 14 postinfection, lymphoid organs were collected to determine
lymphoid organ/body weight ratios. Organ/body weight ratios between groups
were analyzed by using the Kruskal-Wallis test with significance set at P  0.05.
(ii) Experiment 2. To study the role of the Meq homodimers on oncogenesis,
SPF (Hy-Vac) day-old chicks (nine per group) were inoculated subcutaneously
with 2,000 PFU of virus rMd5, rMd5-MeqGCN, or rMd5Meq and reared in
modified Horsfall-Brauer isolation units for 8 weeks. Weekly mortality was
recorded, and all chickens were necropsied at time of death or at termination of
the experiments and evaluated for MDV-specific lesions in the viscera and
nerves. To confirm that the phenotypic changes observed in rMd5-MeqGCN
were due to the exclusive homodimerization of Meq, a revertant virus (rMd5-
MeqGCNR) was inoculated into three chickens (3,000 PFU) and evaluated for
MDV specific lesions.
(ii) Experiment 3. To study the role of Meq homodimers on horizontal trans-
mission, six SPF (Charles River) day-old chicks were inoculated subcutaneously
with 3,000 PFU with rMd5 or rMd5-MeqGCN; three additional uninoculated
chicks were reared with each group and served as contacts to assess horizontal
transmission. At 8 weeks postinfection, buffy coats were obtained from hepa-
rinized blood by centrifugation at 500  g. DNA was extracted by using a
Purelink Genomic DNA extraction kit (Invitrogen), and PCR was performed
using the MDV-specific Meq primers SR1118 (5-GAT CCC GGG GAG ATG
TCT CAG GAG CCA GAG C-3) and SR1135 (5-GAT CCC GGG TCA GGG
TCT CCC GTC ACC TGG AAA CC-3) to detect the presence of MDV
genome.
Reactivation assay. Buffy coats were collected as described above at days 14
and 21 postinfection. DEF monolayers seeded in 35-mm plates were inoculated
with 106 lymphocytes in duplicate, and viral plaques were counted at 7 days
postinoculation.
RESULTS
Mutations in the leucine zipper of Meq are sufficient to
confer homodimerization. It has previously been shown that
Meq has the ability to form homodimers and heterodimers like
the Jun family of bZIP transcription factors, with which Meq
shares considerable homology (21). It is well established that
the specific amino acid residues within the leucine zipper of
bZIP proteins determine their dimerization properties. Among
these transcription factors, the yeast protein GCN4 is well
characterized, and the leucine zipper region is known to allow
for the exclusive formation of homodimers (16). As in other
studies (10, 11, 14), we also utilized the leucine zipper region
of GCN4 in place of the parental leucine zipper of Meq to
study the function of Meq homodimers in MDV pathogenesis.
The leucine zipper of Meq was successfully “swapped” with the
leucine zipper of GCN4 using overlapping PCR, resulting in a
Meq homodimer mutant, MeqGCN (Fig. 2). The open reading
frames of Meq and MeqGCN, fused to the FLAG and HA
epitope tags (HA-Meq, Flag-Meq, HA-MeqGCN, and Flag-
MeqGCN) were expressed in DF-1 cells. Coimmunoprecipita-
tion experiments were performed with anti-Flag antibody-con-
jugated beads to test whether the leucine zipper mutations in
MeqGCN were sufficient to confer homodimerization (Fig. 3).
First, Flag-Meq or Flag-MeqGCN was cotransfected with HA-
Meq in DF-1 cells (Fig. 3a, left panel). Flag-Meq protein
complexes were immunoprecipitated with anti-Flag antibody
and evaluated for the presence of HA proteins by Western blot
analysis. Flag-Meq, but not Flag-MeqGCN, effectively precip-
itated HA-Meq. Conversely, Flag-MeqGCN precipitated
HA-MeqGCN but not HA-Meq (Fig. 3a, right panel). These
results demonstrated the strong homodimerization property of
MeqGCN.
As a next step, the ability of Meq and MeqGCN to dimerize
with c-Jun or c-Fos was examined (Fig. 3b). Meq or MeqGCN
was coexpressed with c-Fos or c-Jun, and their ability to het-
erodimerize with other bZIP family protein assessed. As shown
in the left panel of Fig. 3b, while Meq effectively pulled down
c-Fos, very little, if any, c-Fos was found to associate with
MeqGCN. Likewise, c-Jun interacted with Meq much more
avidly than MeqGCN. This and the above experiment suggest
that MeqGCN preferentially, if not exclusively, forms ho-
modimer under physiological conditions.
Meq homodimer mutant (MeqGCN) retains DNA binding,
transactivation, and repressive functions. Previous character-
ization of Meq has shown that Meq homodimers and het-
erodimers differ in their DNA binding affinities. Although both
Meq homodimers and heterodimers bind AP-1 sequences,
Meq together with c-Jun bound AP-1 sequences with greater
affinity than Meq alone. In addition, Meq alone bound the
MDV origin of replication (MDV Ori) located in the pp38/14
bidirectional promoter (21). Luciferase reporter assays indi-
cated functional differences between Meq and Meq plus c-Jun
in that although Meq activated the AP-1 containing meq pro-
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moter, Meq plus c-Jun resulted in higher activation. Further-
more, Meq expression was shown to repress the MDV pp38/
pp14 bidirectional promoter, which contains the MDV Ori
(21). Therefore, EMSA and luciferase assays were performed
to test whether the DNA binding and transactivation/repres-
sion functions of MeqGCN were still functional. Recombinant
Flag-Meq and Flag-MeqGCN proteins were prepared from
recombinant baculovirus-infected cells. Recombinant proteins
were incubated with 32P-labeled consensus AP-1 oligonucleo-
tide or an oligonucleotide encompassing a portion of the MDV
Ori. Both Meq and MeqGCN proteins bound both AP-1 and
MDV Ori oligonucleotides, and the intensity of band shifts for
both Meq and MeqGCN decreased in the presence of specific
competitor, indicating specific binding (Fig. 4). Luciferase as-
says were then performed to test the transactivation and re-
pressive functions of MeqGCN compared to Meq. DF-1 cells
were transfected with pcDNA empty vector, pcDNA-Meq, or
pcDNA-MeqGCN, together with pGL3-meq promoter re-
porter vector. As shown in Fig. 5, both Meq and MeqGCN
significantly activated the meq promoter, although MeqGCN
activated the meq promoter to significantly lower levels than
Meq (P  0.05). Luciferase assays were also performed to test
the ability of MeqGCN to repress the previously described
pp38 and pp14 promoters. DF-1 cells were transfected with
pcDNA, pcDNA-Meq, or pcDNA-MeqGCN and either the
pGL3-pp38 or the pGL3-pp14 promoter reporter vectors. Al-
though pcDNA-Meq and pcDNA-MeqGCN significantly re-
pressed the pp38 promoter, only pcDNA repressed the pp14
promoter (P  0.05) (Fig. 5). Nonetheless, both pcDNA-Meq
FIG. 3. Homo- and heterodimerization of Meq and MeqGCN. (a) Coimmunoprecipitation analysis of tagged Meq and MeqGCN proteins. The
indicated plasmids were cotransfected in DF-1 cells. Twenty percent of the total cell lysates that were used for coimmunoprecipitation were also
included as controls. Meq coprecipitates only with Meq (left panel), and MeqGCN coprecipitates only with MeqGCN (right panel), demonstrating
homodimerization. Membranes were reprobed with anti-Flag antibody as a control. (b) MeqGCN had impaired ability to form heterodimer with
c-Jun or c-Fos. The indicated plasmids were cotransfected in DF-1 cells, immunoprecipitated with either anti-Fos or anti-Jun antibody, and blotted
with anti-Meq antibody. Ten percent of the total cell lysates that were used for immunoprecipitation were also included in the same gel as a control.
Both c-Fos and c-Jun are effectively precipitated Meq but only weakly precipitated MeqGCN.
FIG. 4. EMSAs of Meq and MeqGCN protein were performed to
test the DNA binding capacity of MeqGCN. Purified baculovirus-
expressed proteins, Meq and MeqGCN, were incubated with radiola-
beled oligonucleotide probes, followed by gel retardation analysis. Two
different probes were used: a consensus AP-1 oligonucleotide and an
ACACA probe derived from the MDV origin of replication (MDV
Ori). Band shifts are observed by Meq and MeqGCN (black arrow),
the intensity of which decreases in the presence of unlabeled compet-
itor. NS, nonspecific bands.
FIG. 5. Luciferase assays demonstrate that MeqGCN has func-
tional transactivation and repression activities. DF-1 cells were trans-
fected with meq promoter, pp14 promoter, pp38 promoter, or 3X-Ori
luciferase reporter plasmids and pcDNA (empty vector), pcDNA-
Meq, or pcDNA-MeqGCN. Both Meq and MeqGCN activate the meq
promoter and repress the pp38/14 bidirectional promoters and 3X-Ori,
indicating MeqGCN maintains transactivation/repressive functions.
Luciferase values are expressed as the fold difference relative to the
pcDNA vector. Error bars indicate the standard deviation.
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and pcDNA-MeqGCN significantly repressed the pGL2-3X-
Ori, which contains three copies of the sequence element
found in the pp38/14 bidirectional promoter that Meq was
previously reported to bind (21, 29).
Colony formation in soft agar. Colony formation in soft agar
is a marker of transformation, and Meq expression in fibroblasts
has been shown to promote anchorage-independent growth (20).
Soft-agar assay was used to test the ability of Meq homodimers to
promote colony formation in soft agar. Meq and MeqGCN ex-
pression in selected DF-1 cells was confirmed by IFA (Fig. 6a, top
panel). As expected, selected DF-1 cells expressing the pcDNA-
Meq construct formed large colonies in soft agar compared to
control cells selected with pcDNA empty vector (Fig. 6a, bottom
panel). Furthermore, cells expressing pcDNA-Meq had 23-fold
more colonies 100 m in size compared to pcDNA control
cells. In contrast, DF-1 cells expressing pcDNA-MeqGCN only
had 3.5-fold as many colonies 100 m in size compared to
empty vector control cells (Fig. 6b), indicating that Meq ho-
modimers have a reduced potential for transformation in vitro.
Construction of Meq homodimer mutant virus rMd5-
MeqGCN. A recombinant Md5 mutant virus in which the leucine
zipper region of meq was replaced with the corresponding region
of GCN4 (rMd5-MeqGCN) was successfully constructed. The
leucine zipper region of the meq gene was replaced with
the leucine zipper region of GCN4 by overlapping PCR, and the
EcoQ fragment containing the chimeric meqGCN gene was
cloned into the A6meq and SN5meq cosmids. The resultant
cosmids A6-MeqGCN and SN5-MeqGCN, together with cosmids
P89, B40, and SN16, were cotransfected into DEF by the calcium
phosphate method, and a recombinant virus was subsequently
recovered by homologous recombination. Southern blot analyses
were performed to assess the integrity of the rMd5-MeqGCN
viral genome. Genomic DNA from rMd5-, rMd5-MeqGCN-, and
rMd5Meq-infected DEF was digested with EcoRI or PstI and
probed with 32P-labeled Md5 cosmids or EcoQ fragment DNA,
respectively. No differences were observed between rMd5 and
rMd5-MeqGCN EcoRI digestion patterns, confirming the integ-
rity of the recombinant genomes (Fig. 7). DNA from rMd5-,
rMd5-MeqGCN-, and rMd5Meq-infected DEF was also di-
gested with PstI because there is a PstI site located within the
leucine zipper region of the meq gene that is absent in the mutant
MeqGCN gene. As expected, PstI-digested rMd5-MeqGCN
DNA probed with 32P-labeled EcoQ fragment resulted in a single
band compared to two bands observed for rMd5 (Fig. 7). Like
rMd5-MeqGCN, rMd5Meq, also lacks the PstI site due to the
deletion of the meq gene; therefore, a single yet smaller band was
detected by Southern blot (Fig. 7).
IFA was performed to evaluate Meq expression in virus-
FIG. 6. In vitro soft-agar assay demonstrating that MeqGCN has reduced transformation potential. (a) The top row shows immunofluorescence
analysis of Meq expression from pools of selected DF-1 cells transfected with pcDNA, pcDNA-Meq, and pcDNA-MeqGCN. In the bottom panels,
a soft-agar assay was performed using pcDNA, pcDNA-Meq, and pcDNA-MeqGCN selected DF-1 cells to assess anchorage-independent growth.
(b) Number of colonies 100 m observed in cells expressing pcDNA, pcDNA-Meq, or pcDNA-MeqGCN. The average numbers of colonies
counted from three random fields are shown. Error bars indicate the standard deviation.
FIG. 7. Southern blot analysis of rMd5, rMd5-MeqGCN, and
rMd5Meq. (A) DNA was digested with EcoRI and probed with total
viral MDV DNA. The restriction profile of rMd5-MeqGCN is similar
to rMd5, indicating that no gross genome rearrangements occurred.
The arrow indicates the location of the EcoQ fragment. Due to the
meq deletion in the EcoQ fragment of rMd5Meq, this fragment
migrates faster. (B) DNA was digested with PstI and probed with
EcoQ fragment. The introduced LZ mutations in rMd5-MeqGCN
resulted in the loss of a PstI site, and therefore a single band is
observed, in contrast to the two bands for rMd5. Likewise, rMd5Meq
does not have a PstI site and, as a consequence of the meq deletion,
results in a faster-migrating single band.
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infected DEF. Meq expression was observed in both rMd5-
and rMd5-MeqGCN-infected DEF but not in rMd5Meq-in-
fected cells. In addition, a magnification of 1,000 clearly
showed that expression of MeqGCN localized to the nucleus
(Fig. 8). Although less expression was observed in rMd5-
MeqGCN compared to rMd5, this correlates with luciferase
data, which indicated that MeqGCN activated the meq pro-
moter to a lesser extent than parental Meq (Fig. 5).
In vitro and in vivo replication of rMd5-MeqGCN. The in
vitro growth properties of rMd5-MeqGCN were tested to as-
sess whether the leucine zipper mutations had any effect on
virus replication in vitro. Our results indicate that rMd5 and
rMd5-MeqGCN virus replicated similarly at the time points
tested (days 0, 2, 4, and 6) (Fig. 9). To test the role of Meq
homodimers in in vivo replication, 4-week-old SPF chickens
were inoculated with 3,000 PFU of rMd5, rMd5-MeqGCN, or
rMd5Meq virus. At 6 days after inoculation, two randomly
selected birds were euthanized, and lymphoid organs (thymus,
spleen, and bursa of Fabricius) were collected and evaluated
for viral lytic antigen (pp38) expression by IHC. Expression of
pp38 was evident in the bursa of Fabricius (Fig. 10), thymus,
and spleen (data not shown) with both rMd5- and rMd5-
MeqGCN-infected chickens, indicating that the leucine zipper
mutations in the rMd5-MeqGCN virus did not affect early
cytolytic infection. To further assess the role of Meq ho-
modimers in viral replication, lymphoid organ body weight
ratios were determined from three birds from each group at
day 14 postinfection to evaluate lymphoid organ atrophy. As
expected, splenomegaly, as well as thymic and bursal atrophy,
was observed in chickens inoculated with rMd5, indicating high
levels of cytolytic infection. Although there were no significant
differences between all groups, bursal and thymic atrophy were
less evident in the rMd5-MeqGCN group compared to the
rMd5 group (Fig. 11).
It is well documented that MDV switches from an active
cytolytic infection to a latent infection approximately 7 to 8
days postinfection, and virus reactivation can be observed
when latently infected lymphocytes are cocultured with fibro-
blasts (2). To examine whether Meq homodimers are involved
FIG. 9. In vitro growth properties of rMd5 and rMd5-MeqGCN.
DEFs were infected with the indicated viruses and harvested on days
2, 4, and 6 after infection, and titers were determined on fresh DEF.
Day 0 indicates the titer of the virus in the inoculum. The experiment
was performed in duplicate, and the titer (logarithm of the mean
number of PFU per dish) is indicated.
FIG. 8. Immunofluorescence analysis of DEF cells infected with
recombinant viruses. (a) rMd5Meq-infected DEF (magnification,
100); (b) rMd5-MeqGCN-infected DEF (magnification, 100); (c)
rMd5-infected DEF (magnification, 100); (d) rMd5-MeqGCN-in-
fected DEF (magnification, 1,000). Meq expression is observed in
the nucleus of rMd5- and rMd5-MeqGCN-infected DEF but not
rMd5Meq-infected DEF.
FIG. 10. Infection of lymphoid tissue and feather follicles. Immu-
nohistochemistry of bursa and feather follicle at days 6 and 21 postin-
fection, respectively, with anti-pp38 monoclonal antibody (H19). Pos-
itive cells are indicated by double staining; counterstaining was
performed with hematoxylin.
FIG. 11. Lymphoid organ/body weight ratios of rMd5-, rMd5-
MeqGCN-, and rMd5Meq-infected chickens day 14 postinfection.
Three birds from each group were euthanized, lymphoid organs were
collected, and chickens and lymphoid organs were weighed. Statistical
analysis was performed by using the Kruskal-Wallis test. Significance
was set at P  0.05. Although no significant differences were observed,
less lymphoid organ atrophy was observed in chickens infected with
rMd5-MeqGCN compared to birds infected with rMd5.
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in the establishment of latency and reactivation, peripheral
blood lymphocytes (buffy coats) were obtained from three
chickens in each group at days 14 and 21 postinfection and
cocultured with DEF. To confirm viral infection, portions of
collected lymphocytes were fixed on microscope slides, and
IFAs were performed to the detect viral antigen, pp38. As
shown in Table 1, few or no plaques were obtained from the
peripheral blood mononuclear cells of chickens infected with
rMd5-MeqGCN and rMd5Meq. However, at day 21, latently
infected lymphocytes were positive for viral antigen pp38 (Fig.
12), suggesting that these viruses are defective in reactivation.
Transmission of MDV occurs through replication of virus in
the feather follicle epithelium (FFE) and release of dander
containing infectious virus (4). Therefore, to determine
whether the rMd5-MeqGCN homodimer mutant was able to
replicate in the FFE, expression of the lytic viral antigen pp38
was evaluated in three chickens from each inoculated group by
IHC. Tissues from all inoculated groups tested positive for
pp38 antigen, indicating the ability of rMd5-MeqGCN, like
rMd5, to replicate in the FFE (Fig. 10). To further assess the
role of Meq homodimers in MDV transmission, day-old SPF
chickens were inoculated with 3,000 PFU of rMd5 or rMd5-
MeqGCN and reared with three uninfected contact chicks.
Buffy coats were collected from contact birds at 8 weeks postin-
fection, DNA was extracted, and PCR for Meq was performed.
In both groups, two out of three contact chickens tested pos-
itive for Meq or MeqGCN, respectively. Altogether, these re-
sults confirm that rMd5-MeqGCN retains the ability to trans-
mit horizontally by shedding through the feather follicle
epithelium.
Oncogenicity of rMd5-MeqGCN. To determine whether Meq
homodimers are involved in transformation of T cells, groups of
nine SPF chickens were inoculated at day of age with 2,000 PFU
of rMd5, rMd5-MeqGCN, or rMd5Meq and then observed for
mortality for a period of 8 weeks. All chickens that died during
the experiment or were euthanized at the termination of the
experiment were evaluated for MDV-specific lesions. MDV-as-
sociated mortality was observed in rMd5-infected chickens start-
ing at week 4 postinfection, and none of the chickens survived the
end of the experiment. In contrast, all of the rMd5-MeqGCN-
infected chickens survived the 8-week experiment, and micro-
scopic examination of the vagus, brachial, and sciatic nerves
showed no signs of Marek’s disease. Similarly, as expected, the
rMd5Meq-infected chickens also survived the duration of the
experiment and were free of MDV- specific lesions (Fig. 13 and
Table 2).
Construction and biological properties of revertant virus
rMd5-MeqGCNR. To verify that the phenotypic changes ob-
served with rMd5-MeqGCN were due to changes introduced
in the leucine zipper region, a revertant virus was constructed.
DNA obtained from rMd5-MeqGCN-infected CEF was co-
transfected with purified parental MDV EcoQ DNA, which
contains the meq gene. A revertant virus, rMd5-MeqGCNR,
was selected by plaque purification and screened for the pres-
ence of both parental and MeqGCN-mutant meq genes by
PCR. PCR revealed that of the 130 plaques tested, 3 contained
one copy of the parental meq gene restored in the viral ge-
TABLE 1. Virus reactivation from peripheral blood lymphocytesa
Group
Avg no. of PFU at:
Day 14 Day 21
rMd5 45 120
rMd5-MeqGCN 1 0
rMd5Meq 2.5 0
a Reactivation assays were performed on days 14 and 21 after inoculation. The
numbers represent the average number of PFU observed when 106 peripheral
blood lymphocytes were cocultured with DEF.
FIG. 12. Detection of MDV pp38 protein in latently infected cells at
21 days postinfection. IFA was performed with anti-pp38 monoclonal
antibody (H19) on peripheral blood mononuclear cells collected from
rMd5- and rMd5-MeqGCN-infected chickens. Texas Red-conjugated sec-
ondary antibodies were used to detect pp38 (white arrows), and nuclei
were stained with DAPI (4,6-diamidino-2-phenylindole).
FIG. 13. Mortality in chickens inoculated with rMd5, rMd5-
MeqGCN, and rMd5Meq. Chickens were inoculated with 2,000 PFU
of the indicated viruses at 1 day of age and maintained in isolation for
8 weeks, and weekly mortality was recorded. Uninoculated chickens
served as negative controls. Chickens that died during the experiment
were evaluated for MDV-specific gross lesions.
TABLE 2. Pathogenicity of rMd5, rMd5-MeqGCN, rMd5Meq,
and rMd5-MeqGCNR in SPF MDV
maternal-antibody-negative chickens
Virus testeda
No. of chickens affected/total no. tested
Mortality (%) Tumor incidence (%)b
rMd5 9/9 (100) 9/9 (100)
rMd5-MeqGCN 0/9 (0) 0/9 (0)
rMd5Meq 0/9 (0) 0/9 (0)
rMd5-MeqGCNRc 3/3 (100) 3/3 (100)
No virus 0/9 (0) 0/9 (0)
a All chickens were inoculated with 3,000 PFU of the indicated viruses.
b Chickens that were not positive for gross tumors were further evaluated for
microscopic tumors.
c Performed as an independent experiment.
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nome. Three chickens were infected with 3,000 PFU of rMd5-
MeqGCNR, and by week 5 postinfection all three were posi-
tive for MDV gross tumors, confirming that the attenuated
phenotype of rMd5-MeqGCN was due to the mutations intro-
duced in the leucine zipper of Meq. In addition, PCR analysis
of virus isolated from the rMd5-MeqGCNR-infected chickens
revealed that both copies of the parental meq gene had been
restored.
DISCUSSION
MDV is a ubiquitous, highly contagious, potent oncogenic
virus, which is controlled by vaccination to prevent economic
losses otherwise caused by Marek’s disease. Due to widespread
use of vaccines, MDV continues to evolve toward greater vir-
ulence and, therefore, a better understanding of the molecular
mechanisms of viral pathogenesis is warranted to control this
economically important disease of poultry.
A number of genes unique to MDV are encoded within the
repeat long region or at its junction with the unique long
region and have been associated with pathogenesis. For exam-
ple, disruption of pp38, vIL8, or LORF11 genes from onco-
genic MDV resulted in reduced tumor incidence as a conse-
quence of impaired lytic replication in chickens (6, 9, 19, 27).
On the other hand, disruption of vTR (viral telomerase RNA)
or meq gene did not appear to have an effect on lytic replica-
tion in vivo but resulted in 60 and 100% reductions in tumor
incidence, respectively (25, 36).
MDV-1 (GaHV-2)-encoded Meq protein is consistently de-
tected in MDV-induced tumors and is a potentially multifaceted
transcription factor that has been shown to directly interact with
cell cycle regulator, cyclin-dependent kinase 2 (CDK2), and the
corepressor C-terminal binding protein (CtBP) (24). Interest-
ingly, abrogation of the interaction of Meq with CtBP in an
MDV-1 recombinant virus (pRB1B-Ct20) resulted in loss of
transformation; however, the molecular mechanisms associated
with this phenotype remain to be elucidated (1), although it can
be speculated that Meq may interfere with the ability of CtBP to
function as a corepressor, as has been described for adenovirus
early region 1A (9a).
Meq shares homology with the Jun/Fos bZIP family of tran-
scription factors, of which viral counterparts v-Jun and v-Fos
are oncogenic, therefore implying a similar oncogenic poten-
tial (35). In vitro transformation studies and the loss of trans-
formation observed in vivo with rMd5Meq provides convinc-
ing proof that Meq is essential for transformation by MDV.
However, the mechanisms of Meq transformation remain un-
known. In vitro characterization of Meq DNA binding and
transactivation or repression activities have provided support
for the hypothesis that Meq homodimers and heterodimers
have distinct roles in MDV-1 pathogenesis (13, 20, 21, 29);
however, the role of Meq homodimers and heterodimers in
MDV-1 pathogenesis has not been characterized.
In the present study, a recombinant virus in which the
leucine zipper of the Meq protein was replaced with
the leucine zipper of the yeast GCN4 protein was successfully
generated. It has been well established that the leucine zipper
region of bZIP proteins determines their dimerization speci-
ficity, which in turn affects their DNA binding properties (16,
38). The mutant Meq protein we generated containing the
dimerization domain of GCN4 retained both DNA binding
and transactivation/repression functions in vitro. However,
rMd5-MeqGCN expressed MeqGCN to a lesser extent than
parental rMd5 virus expressed Meq in infected DEF (Fig. 8).
This correlates with in vitro luciferase data, which showed that
parental Meq activates the meq promoter at significantly
greater levels than MeqGCN (Fig. 5), supporting a previous
report that Meq, together with c-Jun, has a greater binding
affinity for AP-1 sequences and higher transactivation activity
on the meq promoter than Meq alone (21). Since MeqGCN
transactivates the Meq promoter to a lesser extent than paren-
tal Meq, it is possible that MeqGCN may also have decreased
the transactivation of other AP-1-containing promoters. This
decrease in transactivation potential could contribute to the
decreased transformation observed by MeqGCN in the soft-
agar assay (Fig. 6). However, transactivation activity does not
always correlate with transformation, as has been observed in
studies with v-Jun mutants that are strong transactivators and
poor transformers and vice versa (10). We also found that
MeqGCN homodimers had a reduced ability to transrepress
the pp38/14 promoter, although MeqGCN repressed MDVOri
sequences found within the pp38/14 promoter at levels com-
parable to parental Meq. It is possible that MeqGCN ho-
modimers in the context of the full pp38/14 promoter are not
able to bind the pp38/14 promoter, as well as parental Meq or
bind other elements in the promoter with different affinities,
therefore decreasing transrepression. It has been shown that
v-Jun-GCN4 leucine zipper chimeric proteins are more stable
than parental v-Jun homodimers, and it is therefore possible
that the stability of MeqGCN homodimers be different than
that of parental Meq homodimers.
The contribution of other MDV proteins or cellular factors
to MDV transformation cannot be dismissed either. Disrup-
tion of Meq contact with CtBP resulted in a loss of oncoge-
nicity showing the importance of Meq and CtPB interactions
(1). In addition, Meq has been shown to associate with cell
cycle regulators, CDK2, and p53 (17, 24), although the contri-
butions of these interactions in MDV transformation have not
been defined. It remains possible that MeqGCN homodimers
have altered interactions with these or other unknown cellular
factors. However, taken together, our data demonstrate that
MeqGCN homodimers are not sufficient to induce transforma-
tion of T cells in chickens. Further investigations with Meq
heterodimer mutants might aid in further defining the role of
Meq in MDV transformation.
The role of Meq homodimers in MDV-1 pathogenesis was
determined by evaluating both cytolytic infection and transfor-
mation in vivo. In vitro, rMd5-MeqGCN replicated similar to
the parental virus and, in vivo, cytolytic infection was evident in
lymphoid organs and feather follicles, as assessed by the ex-
pression of MDV-1 lytic protein pp38 (Fig. 10). However,
evaluation of effects of MeqGCN on cytolytic infection is dif-
ficult because Meq expression is not essential for early cytolytic
infection (25). Meq is not always detected early in infection,
and expression of Meq in vivo is variable and has been shown
to depend on the virus strain and chicken line used (8, 26).
Since the FFE is the site of fully productive infection and
source of horizontal transmission (4), we evaluated the role of
Meq homodimers on transmission by IHC (Fig. 10) and con-
tact transmission. Our results show that Meq homodimeriza-
VOL. 83, 2009 HOMODIMERIZATION OF MDV-ENCODED Meq PROTEIN 867
 o
n
 Septem
ber 12, 2018 by guest
http://jvi.asm.org/
D
ow
nloaded from
 
tion did not interfere with either replication in the FFE or
transmission to contact chickens.
Atrophy of thymus and bursa of Fabricius and splenomegaly
is a marker of MDV-1 lytic infection and is a good indicator of
the virulence of MDV-1 pathotypes. Atrophy is evident as
early as 8 days postinfection with no significant differences
observed among MDV-1 pathotypes. However, at day 14
postinfection, although lymphoid organ atrophy is less than at
day 8 postinfection, significant differences between MDV-1
pathotypes are evident. By day 14 postinfection, less atrophy is
observed with less-virulent pathotypes, indicating the affected
tissues are able to recover. On the other hand, a greater degree
of atrophy at day 14 postinfection is observed with the more
virulent pathotypes. However, it is still unknown whether
more-virulent strains are able to infect a greater number of cell
types or whether they maintain a prolonged cytolytic infection,
therefore causing more damage to tissue than is caused by
less-virulent strains (5). To assess the virulence of rMd5-
MeqGCN, lymphoid organ/body weight ratios were deter-
mined for rMd5-MeqGCN-, rMd5-, and rMd5Meq-infected
chickens. As expected, lymphoid organ atrophy and spleno-
megaly were observed at day 14 postinfection in the rMd5-
infected group, whereas rMd5-MeqGCN-infected chickens
displayed less lymphoid organ atrophy and were more similar
to uninfected controls (Fig. 11). Although no significant dif-
ferences were observed at day 14 among all groups, the statis-
tical power of the time point was limited due to the small
number of chickens examined and may not accurately reflect
the biological differences between these viruses. However,
these results suggest that rMd5-MeqGCN is less virulent than
parental rMd5.
One of the goals of the present study was to dissect the Meq
functions in the hope of separating its transforming potentials
from the in vivo replication/latency functions. A perhaps over-
simplified model is that Meq/Jun heterodimers, like v-Jun,
impart transforming function, whereas Meq/Meq homodimers
are involved in latency entry and/or reactivation. To test this
model, the replicative properties of rMd5-MeqGCN virus were
assessed in vivo by evaluating early cytolytic infection and
reactivation from latency. Although early cytolytic infection
was not impaired (Fig. 10), the virus appeared to be defective
in reactivation (Table 1). A switch from lytic to latent infection
in MDV-1 normally occurs at approximately 7 days postinfec-
tion, and virus from latently infected cells can be reactivated
when cocultured with fibroblasts in vitro (2). In our study, few
viral plaques were detected at day 14, and none were detected
at day 21 for both the rMd5-MeqGCN and the rMd5Meq
groups. However, although not quantitative, the presence of
latently infected cells in the chickens was confirmed by the
detection of viral antigen pp38 (Fig. 12) and PCR amplification
of the MDV-1 genome (data not shown) in all infected groups.
Since both rMd5-MeqGCN and rMd5Meq viruses appear to
be defective in reactivation, it may be argued that Meq het-
erodimers might play an important role in virus reactivation
from latency.
Inoculation of chickens with rMd5-MeqGCN also showed that
this recombinant virus is apathogenic. During the 8-week exper-
iment, none of the chickens infected with rMd5-MeqGCN devel-
oped gross or microscopic tumors, whereas in the rMd5 group all
of the chickens that died or were euthanized suffered from
Marek’s disease (Fig. 13). Like rMd5Meq, rMd5-MeqGCN did
not transform T cells, further supporting in vitro data and impli-
cating Meq heterodimers in MDV-1 transformation. In order to
rule out the possibility that tumor formation was inhibited by the
production of antibodies directed toward the GCN leucine zip-
per, we tested convalescent chicken serum on cells expressing
Meq and MeqGCN by IFA. None of the sera obtained from
rMd5- or rMd5-MeqGCN-infected chickens reacted positively
with cells expressing either Meq or MeqGCN (data not shown).
These results are further supported by previous work with retro-
virus constructs expressing v-Jun GCN4 leucine zipper mutants,
which remained oncogenic in infected chickens (10, 14). This
suggests that immune responses to MeqGCN did not contribute
to the lack of oncogenicity observed in rMd5-MeqGCN-infected
chickens. Importantly, the phenotypic differences observed in the
present study for rMd5-MeqGCN can be attributed to the leucine
zipper mutations, since the Md5 phenotype was fully restored in
the revertant virus rMd5-MeqGCNR.
In summary, the present study provides the first in vivo
evidence that Meq homodimers are not sufficient for MDV-1
transformation, reinforcing the notion that the participation of
Meq/Jun may be crucial to its transforming ability. In order to
better characterize the Meq transcriptional pathways involved
in MDV-1 pathogenesis, studies with recombinant Meq het-
erodimer virus are under way to investigate the role of Meq-
Jun heterodimers in MDV transformation in vivo.
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